In the U.S., atrial fibrillation (AF), a heart condition that causes an irregular heartbeat in the upper chambers of the ...

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, today ...

Atrial fibrillation and some cardiac death were the 2 big ones with ibrutinib ... Extended follow-up of ALPINE randomized ...

A combination of Imbruvica and venetoclax showed significantly prolonged progression-free survival in patients with untreated ...

The first-in-human trial is taking place at Na Homolce hospital in Prague, Czech Republic, and will treat up to 50 patients.

The global Ablation Technology Market is projected to reach USD 13.61 Billion by 2031 from USD 5.78 Billion in 2024, at a CAGR of 9.34% from 2024 to 2031.Luton, Bedfordshire, United Kingdom, Dec. 18, ...

Patients with pulmonary arterial hypertension and cardiovascular comorbidities may benefit from the use of inhaled or oral ...

Two posters presented at the 2024 American Society of Hematology meeting evaluated overall survival and cost-offset of ...

Background Cardiac amyloidosis (CA) is an underdiagnosed, progressive and lethal disease. Machine learning applied to common ...

CardioFocus announced that investigators completed the first series of treatments in a study of its OptiShot pulsed-field ...

The China 3D cardiac mapping market has showcased significant growth, with its valuation increasing from $55.55 million in 2019 to a projected $150.59 million by 2027. This report offers a detailed ...